MetaCap

Who Owns Purple Biotech Stock?

NASDAQ: PPBTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.02 (-1.37%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
10.83%
Institutional holders
16
  • Institutions 0.0%
  • Insiders 100.0%
  • Public and other 0.0%

Who owns Purple Biotech stock?

Institutional investors own about 10.8% of Purple Biotech's shares, spread across 16 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 188.93% of PPBT.

The largest institutional holders are Smartharvest Portfolios, LLC (1.76%), HRT Financial LP (0.90%) and Citadel Advisors Llc (0.81%). Together, the top 10 institutions control 5.2% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their PPBT positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of PPBT

Purple Biotech top institutional holders
InstitutionShares% HeldChange
Smartharvest Portfolios, LLC28.47K1.76%+57.0%
HRT Financial LP14.64K0.90%+100.0%
Citadel Advisors Llc13.17K0.81%+100.0%
Susquehanna International Group, LLP12.85K0.79%-75.9%
Independent Advisor Alliance11.90K0.73%+100.0%
Arax Advisory Partners1.45K0.09%+100.0%
Rhumbline Advisers8560.05%+20.6%
UBS Group AG7510.05%+658.6%
Morgan Stanley1970.01%-65.9%
Royal Bank of Canada1280.01%+1180.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of PPBT

Purple Biotech top fund holders
FundShares% Held
Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St100.00%

Frequently asked questions

Who is the largest shareholder of Purple Biotech?

Smartharvest Portfolios, LLC is the largest institutional shareholder of PPBT, owning 1.76% of shares outstanding (28.47K shares) as of its latest 13F filing.

What percentage of Purple Biotech is owned by institutions?

Institutions own about 10.8% of PPBT shares and -12.2% of the public float.

How much of Purple Biotech do insiders own?

Insiders, such as officers and directors, own about 188.93% of PPBT shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related